Ilsung IS

Inhaled anaesthetic Sevoprane (sevoflurane inhalation solution), first exported to Uzbekistan in March 2026; anaesthetics made at the first Ansan plant are exported abroad.

Sugammadex sodium injection for reversing neuromuscular blockade, presented in 1 mL and 2 mL presentations.

Product range covering antibiotics, respiratory, diabetes, muscle-relaxant and neuromuscular-blocking drugs, anaesthetics, cardiovascular and digestive medicines, antivirals, anticoagulants, contrast agents and medical devices.

GMP plant completed in Ansan, Gyeonggi-do, in 1987. Plant 1 makes cardiovascular, antiviral, bone and ophthalmic products and anaesthetics; Plant 2, completed in 2008, is a penicillin facility producing Augmentin products with GSK and holds Japanese Ministry of Health GMP certification.

Signed an R&D agreement with Enisolution, a subsidiary of Kukjeon Pharm, to co-develop first generics, incrementally modified drugs and new formulations; Enisolution handles product development and formulation design, Ilsung IS sales and commercialisation.

Made the first export of Sevoprane inhalation solution to Uzbekistan.

The production division obtained integrated certification for environmental management (ISO 14001) and occupational health and safety management (ISO 45001).

With Gabia, completed a proof of concept in five departments (medical, HR, IT, finance and sales planning) in which non-developer staff design and run their own work AI agents.